INTS 8-K 2026-11-05

INTENSITY THERAPEUTICS, INC. (INTS) 8-K dated 2026-11-05 — accession 0001567264-26-000068.

INTENSITY THERAPEUTICS, INC. (INTS) is a biotechnology company listed on US.

INTS: Intensity Therapeutics Reports Third Quarter 2026 Financial Results and…

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for INTS is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The INTS SEC hub lists recent forms. The stock page is the research view.